Bu sayfada
01PFE fiyat
02Anlık Görüntü
03Grafik
04Hisse bölünmeleri
05Hakkında
06Performans
07Değerleme ve oranlar
13Temettüler
14Kazançlar
15Tüm Temeller
16Finansal Tablolar
17Kurumsal Sahipler (13F)
18Aktivistler ve %5+ sahipler
19Şirket yöneticileri
20ETF sahipliği
21Konsensüs
22Akranlar
23Haberler
26Metriklerim
PFE Pfizer, Inc. Common Stock
NYSE · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 4, 2026
$27,80
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$23,6252 haftanın en düşüğü
$29,2152 haftanın en yükseği
P/E (TTM)
36.6
Hisse Başına Kâr (TTM)
$0.76
Gelir (TTM)
$63.70B
rozetleriniz
52 Haftlık Aralık
$24–$29
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
$29
P/E
36.6
ROE
5.0%
Net Kâr Marjı
6.8%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
PFE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$27.80
P/E (TTM)
36.6
Hisse Başına Kâr (TTM)
$0.76
Gelir (TTM)
$63.70B
ROE (TTM)
5.0%
D/E Borç/Özsermaye (MRQ)
0.7
52 Haftlık Aralık
$24–$29
PFE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 17 Kasım 2020 | 527-for-500 | İleri |
| 01 Temmuz 1999 | 3-for-1 | İleri |
| 01 Temmuz 1997 | 2-for-1 | İleri |
| 03 Temmuz 1995 | 2-for-1 | İleri |
| 01 Nisan 1991 | 2-for-1 | İleri |
| 01 Temmuz 1983 | 2-for-1 | İleri |
Pfizer, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Pfizer, dünyanın önde gelen ilaç şirketlerinden biridir. Alman asıllı bilim insanları Charles Pfizer ve Charles Erhart adlı kuzenler tarafından 1849 yılında New York'ta kurulmuş olup; hâlâ etkinliğini sürdürmektedir. Türkiye'deki faaliyetlerine 1957'de başlamıştır.
Pfizer, immünoloji, onkoloji, kardiyoloji, endokrinoloji ve nöroloji için ilaç ve aşılar geliştirir ve üretir. Şirketin, her biri yıllık geliri 1 milyar ABD dolarından fazla olan çok sayıda gişe rekorları kıran ilaçları veya ürünleri bulunmaktadır. 2020'de şirketin gelirlerinin %52'si Amerika Birleşik Devletleri'nden, %6'sı Çin ve Japonya'dan ve %36'sı diğer ülkelerden geldi.[1]
### Covid-19 Aşısı
Pfizer, BioNTech ile ortaklaşa geliştirdiği COVID-19 aşısının %95'lere varan etkililik oranı ile başarıya ulaştığını açıkladı. Yetkililer denemeler sırasında kayda değer bir güvenlik sorunuyla karşılaşmadıklarını da açıkladı.
== Kaynakça ==
Kaynak: Wikipedia, CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
sektörHealthcare
endüstriPharmaceuticals
çalışanlar75.000
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$62.58B2016-12-31 → 2025-12-31
Hisse Başına Kâr$1.362016-12-31 → 2025-12-31
Serbest Nakit Akışı$9.07B2016-12-31 → 2025-12-31
Net kar marjı6.8%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | PFE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 36.65Y ort. ≈27.9 | ≈27.9 | 31.0 | Adil değer |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | PFE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| EBITDA Margin (FAVÖK Marjı) | 10.5%5Y ort. ≈8.7% | ≈8.7% | 8.3% | En üst düzey | |
| Vergi Öncesi Kar Marjı (TTM) | 6.6%5Y ort. ≈18.2% | ≈18.2% | 15.0% | Zayıf | |
| Net Kâr Marjı (TTM) | 6.8%5Y ort. ≈17.4% | ≈17.4% | 10.4% | Zayıf | |
| ROA (TTM) | 2.1%5Y ort. ≈7.6% | ≈7.6% | 9.8% | Zayıf | |
| ROE (TTM) | 5.0%5Y ort. ≈17.6% | ≈17.6% | 25.3% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | PFE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.75Y ort. ≈0.6 | ≈0.6 | 0.9 | Düşük borç | |
| Cari Oran (MRQ) | 1.35Y ort. ≈1.2 | ≈1.2 | 1.6 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 0.45Y ort. ≈0.3 | ≈0.3 | 0.8 | Düşük likidite | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 0.75Y ort. ≈0.6 | ≈0.6 | 0.9 | Düşük borç |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | PFE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -1.7%5Y ort. ≈16.7% | ≈16.7% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -14.8%5Y ort. ≈-3.3% | ≈-3.3% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 8.5% | · | · | · | |
| EPS YoY (EPS YB) | -3.5%5Y ort. ≈72.5% | ≈72.5% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | -3.2%5Y ort. ≈73.0% | ≈73.0% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | -37.1%5Y ort. ≈-34.9% | ≈-34.9% | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | -3.6% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | -37.2%5Y ort. ≈-34.8% | ≈-34.8% | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | -3.2% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | PFE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.35Y ort. ≈0.4 | ≈0.4 | 0.5 | Zayıf | |
| Inventory Turnover (Stok Devir Hızı) | 1.55Y ort. ≈2.6 | ≈2.6 | 1.5 | Aynı seviyede | |
| Receivables Turnover (Alacak Devir Hızı) | 5.45Y ort. ≈6.7 | ≈6.7 | 5.6 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$834.4K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Yıllıklaştırılmış Ödeme≈$1.72
5 Yıllık Temettü CAGR≈3.6%
Büyüme Serisi≈16
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Tem 24, 2026 | $0,43 | USD | ≈7.0% |
| May 8, 2026 | $0,43 | USD | ≈6.7% |
| Oca 23, 2026 | $0,43 | USD | ≈6.7% |
| Kas 7, 2025 | $0,43 | USD | ≈7.0% |
| Tem 25, 2025 | $0,43 | USD | ≈6.9% |
| May 9, 2025 | $0,43 | USD | ≈7.6% |
| Oca 24, 2025 | $0,43 | USD | ≈6.5% |
| Kas 8, 2024 | $0,42 | USD | ≈6.3% |
| Tem 26, 2024 | $0,42 | USD | ≈5.4% |
| May 9, 2024 | $0,42 | USD | ≈5.9% |
| Oca 25, 2024 | $0,42 | USD | ≈6.0% |
| Kas 9, 2023 | $0,41 | USD | ≈5.5% |
| Tem 27, 2023 | $0,41 | USD | ≈4.5% |
| May 11, 2023 | $0,41 | USD | ≈4.3% |
| Oca 26, 2023 | $0,41 | USD | ≈3.6% |
| Kas 3, 2022 | $0,40 | USD | ≈3.4% |
| Tem 28, 2022 | $0,40 | USD | ≈3.1% |
| May 12, 2022 | $0,40 | USD | ≈3.1% |
| Oca 27, 2022 | $0,40 | USD | ≈2.9% |
| Kas 4, 2021 | $0,39 | USD | ≈3.6% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
22.6%
Sonraki Rapor
Kas 02, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 3, 2026 | $0.77 | $0.69 | 11.4% |
| 31 Mart 2026 | $0.75 | $0.72 | 3.5% | |
| 31 Aralık 2025 | $0.66 | $0.58 | 14.3% | |
| 30 Eylül 2025 | $0.87 | $0.64 | 36.0% | |
| 30 Haziran 2025 | $0.78 | $0.59 | 32.9% | |
| 31 Mart 2025 | $0.92 | $0.67 | 37.5% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $62.58B | $63.63B | $59.55B | $101.17B | $81.29B | $41.65B | $40.91B | $40.83B | · | $52.82B | $48.85B | |
| Cost of Revenue | $16.07B | $17.85B | $24.95B | $34.34B | $30.82B | $8.48B | $8.05B | $8.99B | · | $12.32B | $9.65B | |
| SG&A Expense | $13.79B | $14.73B | $14.77B | $13.68B | $12.70B | $11.60B | $12.73B | $12.61B | · | $14.84B | $14.81B | |
| Interest Expense | $2.67B | $3.09B | $2.21B | $1.24B | $1.29B | $1.45B | $1.57B | $1.32B | · | $1.19B | $1.20B | |
| Interest Income | $603M | $545M | $1.62B | $251M | $36M | $73M | $225M | $333M | · | $470M | $471M | |
| Other Non-op | $-6.72B | $-4.39B | $-222M | $-1.06B | $4.88B | $-1.21B | $-3.50B | $-2.08B | · | $-3.79B | $-2.86B | |
| Pretax Income | $7.52B | $8.02B | $1.06B | $34.73B | $24.31B | $7.04B | $11.32B | $3.59B | · | $8.35B | $8.96B | |
| Income Tax | $-266M | $-28M | $-1.11B | $3.33B | $1.85B | $370M | $583M | $-266M | · | $1.12B | $1.99B | |
| Net Income | $7.77B | $8.03B | $2.12B | $31.37B | $21.98B | $9.16B | $16.03B | $11.15B | · | $7.21B | $6.96B | |
| EPS (Basic) | $1.37 | $1.42 | $0.38 | $5.59 | $3.92 | $1.65 | $2.88 | $1.90 | · | $1.18 | $1.13 | |
| EPS (Diluted) | $1.36 | $1.41 | $0.37 | $5.47 | $3.85 | $1.63 | $2.82 | $1.87 | · | $1.17 | $1.11 | |
| Shares (Basic) | 5,683,000,000 | 5,664,000,000 | 5,643,000,000 | 5,608,000,000 | 5,601,000,000 | 5,555,000,000 | 5,569,000,000 | 5,872,000,000 | · | 6,089,000,000 | 6,176,000,000 | |
| Shares (Diluted) | 5,713,000,000 | 5,700,000,000 | 5,709,000,000 | 5,733,000,000 | 5,708,000,000 | 5,632,000,000 | 5,675,000,000 | 5,977,000,000 | · | 6,159,000,000 | 6,257,000,000 | |
| EBITDA | $6.59B | $7.01B | $6.29B | $5.06B | $5.19B | · | $6.01B | $6.38B | · | $5.76B | $5.16B |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.14B | $1.04B | $2.85B | $416M | $1.94B | $1.79B | $1.12B | $1.14B | · | $2.60B | $3.64B | |
| Short-term Investments | · | · | · | · | · | $10.44B | $8.53B | $17.69B | · | $15.26B | $19.65B | |
| Receivables | $11.87B | $11.46B | $11.57B | $10.95B | $11.48B | $7.91B | $6.77B | $8.03B | $8.23B | $8.22B | $8.18B | |
| Inventory | $10.65B | $10.85B | $10.19B | $8.98B | $9.06B | $8.02B | $7.07B | $7.51B | $7.57B | $6.78B | $7.51B | |
| Other Current Assets | $2.81B | $4.25B | $4.91B | $5.02B | $3.82B | $3.65B | $2.36B | $2.46B | · | $2.25B | $2.15B | |
| Current Assets | $42.90B | $50.36B | $43.33B | $51.26B | $59.69B | $35.07B | $32.80B | $49.93B | · | $38.95B | $43.80B | |
| PP&E (Net) | $19.32B | $18.39B | $18.94B | $16.27B | $14.88B | $13.74B | $12.97B | $13.38B | · | $13.32B | $13.77B | |
| PP&E (Gross) | $36.70B | $34.88B | $34.98B | $31.45B | $29.95B | $28.41B | $27.96B | $29.98B | · | $28.12B | $27.27B | |
| Accum. Depreciation | $17.39B | $16.48B | $16.05B | $15.17B | $15.07B | $14.66B | $14.99B | $16.59B | · | $14.81B | $13.50B | |
| Goodwill | $71.26B | $68.53B | $67.78B | $51.38B | $49.21B | $49.56B | $48.18B | $42.93B | · | $54.45B | $48.24B | |
| Intangibles | $53.73B | $55.41B | $64.90B | $43.37B | $25.15B | $28.34B | $33.94B | $35.21B | · | $52.65B | $40.36B | |
| Other Non-current Assets | $9.63B | $9.82B | $12.47B | $13.16B | $7.68B | $4.88B | $4.20B | $2.80B | $3.02B | $3.32B | $3.42B | |
| Total Assets | $208.16B | $213.40B | $226.50B | $197.21B | $181.48B | $154.23B | $167.59B | $159.42B | · | $171.62B | $167.38B | |
| Accounts Payable | $5.24B | $5.63B | $6.71B | $6.81B | $5.58B | $4.28B | $3.89B | $4.67B | · | $4.54B | $3.62B | |
| Short-term Debt | $0 | $2.45B | $7.96B | $0 | $0 | $556M | $13.91B | $3.10B | · | $5.80B | · | |
| Current Liabilities | $36.98B | $42.99B | $47.79B | $42.14B | $42.67B | $25.92B | $37.30B | $31.86B | · | $31.11B | $29.40B | |
| Capital Leases | $2.29B | $2.29B | $2.63B | $2.60B | $2.51B | $1.11B | $1.03B | · | · | · | · | |
| Deferred Tax | $2.40B | $2.12B | $640M | $1.02B | $349M | $4.06B | $5.65B | $3.70B | $3.99B | $30.75B | $26.88B | |
| Other Non-current Liabilities | $14.72B | $14.15B | $16.54B | $13.18B | $9.74B | $6.67B | $6.89B | $5.85B | $5.69B | $6.34B | $5.26B | |
| Total Liabilities | $121.39B | $124.90B | $137.21B | $101.29B | $104.01B | $90.76B | $104.15B | $95.66B | · | $111.78B | $102.38B | |
| Long-term Debt | $64.64B | $61.15B | $63.79B | $35.44B | $37.83B | $4.00B | $37.42B | $37.69B | · | $31.40B | $28.82B | |
| Total Debt | $64.64B | $63.60B | $71.76B | $35.44B | $37.83B | $39.69B | $51.33B | $40.78B | · | $35.62B | $32.54B | |
| Common Stock | $481M | $480M | $478M | $476M | $473M | $470M | $468M | $467M | · | $461M | $459M | |
| Paid-in Capital | $94.47B | $93.60B | $92.63B | $91.80B | $90.59B | $88.67B | $87.43B | $86.25B | · | $82.69B | $81.02B | |
| Retained Earnings | $114.61B | $116.72B | $118.35B | $125.66B | $103.39B | $90.39B | $97.67B | $89.55B | $86.47B | $71.77B | $71.99B | |
| Treasury Stock | $115.02B | $114.76B | $114.49B | $113.97B | $111.36B | $110.99B | $110.80B | $101.61B | · | $84.36B | $79.25B | |
| AOCI | $-8.07B | $-7.84B | $-7.96B | $-8.30B | $-5.90B | $-5.31B | $-11.64B | $-11.28B | $-10.23B | $-11.04B | $-9.52B | |
| Stockholders' Equity | $86.48B | $88.20B | $89.01B | $95.66B | $77.20B | $63.24B | $63.14B | $63.41B | · | $59.54B | $64.72B | |
| Liabilities + Equity | $208.16B | $213.40B | $226.50B | $197.21B | $181.48B | $154.23B | $167.59B | $159.42B | · | $171.62B | $167.38B |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6.59B | $7.01B | $6.29B | $5.06B | $5.19B | $4.68B | $5.75B | $6.38B | · | $5.76B | $5.16B | |
| Stock-based Comp | $799M | $877M | $525M | $872M | $1.18B | $755M | $687M | $923M | · | $691M | $669M | |
| Deferred Tax | $-2.13B | $-2.10B | $-3.44B | $-3.76B | $-4.29B | $-1.57B | $561M | $-2.20B | · | $-700M | $-20M | |
| Amort. of Intangibles | · | $5.30B | $4.70B | $3.60B | $3.70B | $3.40B | $4.50B | · | · | · | $3.80B | |
| Restructuring | $1.09B | $1.99B | $1.97B | $882M | $741M | $535M | $227M | $796M | · | $1.05B | $811M | |
| Other Non-cash | $-1.32B | $-1.07B | $3.21B | $-4.28B | $8.52B | · | $-11.03B | $-454M | · | $2.94B | $1.75B | |
| Operating Cash Flow | $11.70B | $12.74B | $8.70B | $29.27B | $32.58B | $14.40B | $12.59B | $15.83B | · | $16.19B | $14.69B | |
| CapEx | $2.63B | $2.91B | $3.91B | $3.24B | $2.71B | $2.23B | $2.05B | $1.98B | · | $1.82B | $1.40B | |
| Investing Cash Flow | $-1.35B | $2.65B | $-32.28B | $-15.78B | $-22.55B | $-4.27B | $-3.94B | $4.53B | · | $-7.79B | $-2.98B | |
| Debt Issued | $9.68B | $0 | $30.83B | $0 | $997M | $5.22B | $4.94B | $4.97B | · | $10.98B | $0 | |
| Net Debt Issued | $2.92B | $-2.25B | $28.26B | $-3.30B | $-1.01B | $1.22B | $-1.86B | $1.41B | · | $3.29B | $-3.00B | |
| Stock Repurchased | · | $0 | $0 | $2.00B | $0 | $0 | $8.87B | $12.20B | · | $5.00B | $6.16B | |
| Net Stock Activity | · | $0 | $0 | $-2.00B | $0 | $0 | $-8.87B | $-12.20B | · | $-5.00B | $-6.16B | |
| Financing Cash Flow | $-10.30B | $-17.14B | $26.07B | $-14.83B | $-9.82B | $-9.65B | $-8.48B | $-20.44B | · | $-9.23B | $-10.41B | |
| Net Change in Cash | $91M | $-1.81B | $2.45B | $-1.51B | $159M | $475M | $125M | $-205M | · | $-1.04B | $298M | |
| Taxes Paid | $4.69B | $3.60B | $3.15B | $7.87B | $7.43B | $3.15B | $3.66B | $3.65B | · | $2.52B | $2.38B | |
| Free Cash Flow | $9.07B | $9.84B | $4.79B | $26.03B | $29.87B | $12.15B | $10.41B | $13.79B | · | $14.08B | $13.12B | |
| Levered FCF | $6.31B | $6.73B | $256M | $24.91B | $28.68B | $10.79B | $8.96B | $12.55B | · | $13.05B | $12.18B |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 12.4% | 12.6% | 3.6% | 31.3% | 27.0% | 22.9% | 31.4% | 20.8% | · | 13.7% | 14.2% | |
| Pretax Margin | 12.0% | 12.6% | 1.8% | 34.6% | 29.9% | 17.9% | 34.2% | 22.1% | · | 15.8% | 18.4% | |
| EBITDA Margin | 10.5% | 11.0% | 10.8% | 5.1% | 6.4% | · | 11.6% | 11.9% | · | 10.9% | 10.6% | |
| ROA | 3.7% | 3.6% | 1.0% | 16.6% | 13.1% | 6.0% | 10.0% | 6.7% | · | 4.3% | 4.2% | |
| ROE | 8.9% | 9.1% | 2.3% | 36.3% | 31.3% | 15.2% | 25.7% | 16.6% | · | 11.6% | 10.2% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.2 | 0.9 | 1.2 | 1.4 | 1.4 | 0.9 | 1.6 | · | 1.3 | 1.5 | |
| Quick Ratio | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.5 | 0.8 | · | 0.8 | 1.1 | |
| Debt / Equity | 0.7 | 0.7 | 0.8 | 0.4 | 0.5 | 0.6 | 0.8 | 0.6 | · | 0.6 | 0.5 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.7 | 0.3 | 0.5 | 0.6 | 0.6 | 0.5 | · | 0.5 | 0.4 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.5 | 0.5 | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | |
| Inventory Turnover | 1.5 | 1.7 | 2.6 | 3.8 | 3.6 | 1.2 | 1.3 | 1.5 | · | 1.7 | 1.5 | |
| Receivables Turnover | 5.4 | 5.5 | 5.3 | 8.9 | 8.4 | 5.7 | 6.2 | 6.6 | · | 6.4 | 5.9 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $10.95 | $11.16 | $10.25 | $17.50 | $14.24 | $7.44 | $9.12 | $8.98 | · | $8.58 | $7.81 | |
| Cash Flow / Share | $2.05 | $2.24 | $1.52 | $5.11 | $5.71 | $2.56 | $2.22 | $2.65 | · | $2.58 | $2.32 | |
| Dividend / Share | $1.72 | $1.69 | $1.65 | $1.61 | $1.57 | $1.53 | $1.46 | $1.38 | · | $1.22 | · | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | $1.20 | $1.12 | |
| EPS (TTM) | $1.36 | $1.41 | $0.37 | $5.47 | $3.85 | $1.63 | $2.82 | $1.87 | · | $1.17 | $1.11 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.7% | 6.8% | -41.1% | 24.5% | 95.2% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -14.8% | -7.8% | 12.7% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.5% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -3.5% | 281.1% | -93.2% | 42.1% | 136.2% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -37.1% | -28.4% | -39.0% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.6% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -3.2% | 279.0% | -93.2% | 42.7% | 140.0% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -37.2% | -28.5% | -38.6% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -3.2% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $62.58B | $63.63B | $59.55B | $101.17B | $81.29B | $41.65B | $40.91B | $40.83B | · | $52.82B | $48.85B | |
| Net Income TTM | $7.77B | $8.03B | $2.12B | $31.37B | $21.98B | $9.16B | $16.03B | $11.15B | · | $7.21B | $6.96B | |
| P/E | 18.3 | 18.8 | 77.8 | 9.4 | 15.3 | 22.6 | 13.2 | 22.1 | · | 26.3 | 27.6 | |
| Earnings Yield | 5.5% | 5.3% | 1.3% | 10.7% | 6.5% | 4.4% | 7.6% | 4.5% | · | 3.8% | 3.6% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15.03B | $14.45B | $17.56B | $16.65B | $14.65B | $13.71B | $17.76B | $17.70B | $13.28B | $14.88B | $14.57B | $13.01B | $18.49B | $25.14B | |
| Cost of Revenue | $4.09B | $3.55B | $5.27B | $4.17B | $3.78B | $2.85B | $5.91B | $5.26B | $3.30B | $3.38B | $7.56B | $3.24B | $4.89B | $9.65B | |
| SG&A Expense | $3.41B | $2.96B | $4.16B | $3.19B | $3.42B | $3.03B | $4.27B | $3.24B | $3.72B | $3.50B | $4.58B | $3.50B | $3.42B | $4.64B | |
| Interest Expense | $667M | $668M | $711M | $652M | $654M | $654M | $740M | $783M | $778M | $790M | $688M | $508M | $318M | $313M | |
| Interest Income | $113M | $115M | $166M | $138M | $156M | $143M | $170M | $116M | $130M | $129M | $609M | $316M | $177M | $137M | |
| Other Non-op | $-3.72B | $-861M | $-4.51B | $-517M | $-739M | $-953M | $-2.36B | $-243M | $-1.11B | $-680M | $159M | $75M | $-275M | $1M | |
| Pretax Income | $-653M | $3.17B | $-1.64B | $3.33B | $3.04B | $2.79B | $-10M | $4.71B | $-103M | $3.42B | $-4.13B | $2.27B | $6.27B | $5.23B | |
| Income Tax | $-407M | $461M | $-2M | $-216M | $141M | $-189M | $-421M | $234M | $-134M | $293M | $-795M | $-71M | $715M | $230M | |
| Net Income | $-248M | $2.69B | $-1.65B | $3.54B | $2.91B | $2.97B | $410M | $4.46B | $41M | $3.12B | $-3.37B | $2.33B | $5.54B | $4.99B | |
| EPS (Basic) | $-0.04 | $0.47 | $-0.28 | $0.62 | $0.51 | $0.52 | $0.07 | $0.79 | $0.01 | $0.55 | $-0.59 | $0.41 | $0.98 | $0.88 | |
| EPS (Diluted) | $-0.04 | $0.47 | $-0.29 | $0.62 | $0.51 | $0.52 | $0.07 | $0.78 | $0.01 | $0.55 | $-0.59 | $0.41 | $0.97 | $0.87 | |
| Shares (Basic) | 5,699,000,000 | 5,691,000,000 | · | 5,685,000,000 | 5,685,000,000 | 5,675,000,000 | · | 5,667,000,000 | 5,666,000,000 | 5,657,000,000 | · | 5,646,000,000 | 5,634,000,000 | · | |
| Shares (Diluted) | 5,699,000,000 | 5,731,000,000 | · | 5,714,000,000 | 5,706,000,000 | 5,710,000,000 | · | 5,705,000,000 | 5,696,000,000 | 5,697,000,000 | · | 5,713,000,000 | 5,727,000,000 | · | |
| EBITDA | $1.62B | $1.61B | · | $1.66B | $1.62B | $1.62B | · | · | · | $1.74B | · | · | · | · |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $976M | $1.70B | $1.14B | $1.34B | $1.64B | $1.43B | $1.04B | $1.09B | $1.05B | $719M | · | $2.63B | $2.17B | · | |
| Receivables | $12.49B | $12.59B | $11.87B | $14.26B | $12.08B | $11.85B | $11.46B | $14.45B | $11.39B | $10.99B | · | $10.23B | $12.30B | · | |
| Inventory | $9.95B | $10.67B | $10.65B | $11.47B | $11.67B | $10.85B | $10.85B | $11.72B | $11.45B | $10.89B | · | $10.31B | $9.54B | · | |
| Other Current Assets | $3.52B | $2.91B | $2.81B | $2.36B | $2.69B | $2.95B | $4.25B | $3.85B | $4.19B | $4.37B | · | $4.83B | $5.12B | · | |
| Current Assets | $41.36B | $42.82B | $42.90B | $46.92B | $43.70B | $45.86B | $50.36B | $43.22B | $37.83B | $42.41B | · | $73.35B | $50.08B | · | |
| PP&E (Net) | $19.03B | $19.40B | $19.32B | $18.88B | $18.78B | $18.35B | $18.39B | $18.54B | $18.96B | $18.80B | · | $17.49B | $17.05B | · | |
| PP&E (Gross) | · | · | $36.70B | · | · | · | $34.88B | · | · | · | · | · | · | · | |
| Accum. Depreciation | $18.10B | $17.80B | $17.39B | $17.50B | $17.27B | $16.84B | $16.48B | $16.68B | $16.57B | $16.36B | · | $15.55B | $15.51B | · | |
| Goodwill | $71.42B | $71.41B | $71.26B | $69.10B | $69.00B | $68.44B | $68.53B | $68.57B | $68.44B | $69.30B | $67.78B | $51.57B | $51.48B | $51.38B | |
| Intangibles | $47.05B | $52.56B | $53.73B | $51.32B | $52.70B | $53.98B | $55.41B | $59.99B | $61.24B | $62.83B | · | $41.41B | $42.00B | · | |
| Other Non-current Assets | $9.94B | $9.83B | $9.63B | $9.32B | $9.46B | $9.85B | $9.82B | $10.49B | $10.71B | $11.20B | · | $13.03B | $12.96B | · | |
| Total Assets | $201.13B | $207.62B | $208.16B | $208.73B | $206.09B | $208.03B | $213.40B | $219.48B | $216.19B | $221.09B | · | $220.17B | $195.62B | · | |
| Accounts Payable | $4.58B | $4.51B | $5.24B | $5.02B | $5.17B | $5.24B | $5.63B | $5.31B | $5.11B | $5.59B | · | $6.08B | $6.12B | · | |
| Short-term Debt | · | · | $0 | $0 | $0 | $155M | $2.45B | $5.84B | $7.96B | $6.93B | · | · | · | · | |
| Current Liabilities | $32.65B | $34.35B | $36.98B | $36.60B | $37.73B | $36.45B | $42.99B | $43.21B | $43.82B | $40.50B | · | $34.65B | $36.56B | · | |
| Capital Leases | · | · | $2.29B | · | · | · | $2.29B | · | · | · | · | · | · | · | |
| Deferred Tax | $1.96B | $2.41B | $2.40B | $2.47B | $2.48B | $2.26B | $2.12B | $2.16B | $2.23B | $931M | · | $1.23B | $1.07B | · | |
| Other Non-current Liabilities | $14.78B | $14.20B | $14.72B | $13.61B | $13.93B | $13.30B | $14.15B | $15.57B | $16.09B | $15.12B | · | $13.40B | $13.01B | · | |
| Total Liabilities | $115.64B | $117.21B | $121.39B | $115.64B | $117.08B | $117.39B | $124.90B | $126.92B | $128.22B | $128.54B | · | $120.88B | $94.38B | · | |
| Long-term Debt | $63.10B | $64.43B | $64.64B | $61.66B | $61.75B | $61.39B | $61.15B | $61.75B | $61.25B | $62.31B | · | $64.92B | $35.27B | · | |
| Total Debt | $63.10B | $64.43B | · | $61.66B | $61.75B | $61.54B | · | $67.59B | $69.22B | $69.24B | · | · | · | · | |
| Common Stock | $482M | $482M | $481M | $481M | $481M | $481M | $480M | $480M | $480M | $480M | · | $478M | $478M | · | |
| Paid-in Capital | $95.03B | $94.77B | $94.47B | $94.25B | $94.05B | $93.86B | $93.60B | $93.48B | $93.20B | $93.00B | · | $92.33B | $92.15B | · | |
| Retained Earnings | $112.09B | $117.24B | $114.61B | $121.15B | $117.61B | $119.59B | $116.72B | $121.06B | $116.60B | $121.32B | · | $128.80B | $131.10B | · | |
| Treasury Stock | $115.19B | $115.19B | $115.02B | $115.01B | $115.01B | $115.01B | $114.76B | $114.76B | $114.76B | $114.75B | · | $114.48B | $114.47B | · | |
| AOCI | $-7.22B | $-7.20B | $-8.07B | $-8.07B | $-8.44B | $-8.58B | $-7.84B | $-7.97B | $-7.82B | $-7.76B | · | $-8.10B | $-8.29B | · | |
| Stockholders' Equity | $85.19B | $90.10B | $86.48B | $92.80B | $88.69B | $90.34B | $88.20B | $92.29B | $87.70B | $92.28B | · | $99.02B | $100.97B | · | |
| Liabilities + Equity | $201.13B | $207.62B | $208.16B | $208.73B | $206.09B | $208.03B | $213.40B | $219.48B | $216.19B | $221.09B | · | $220.17B | $195.62B | · |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.62B | $1.61B | $1.69B | $1.66B | $1.62B | $1.62B | $1.79B | $1.75B | $1.73B | $1.74B | $1.67B | · | $1.49B | $1.52B | |
| Stock-based Comp | $249M | $272M | $225M | $201M | $203M | $170M | $177M | $274M | $206M | $220M | $121M | · | $105M | $364M | |
| Deferred Tax | $-1.32B | $-12M | $-433M | $-765M | $-272M | $-663M | $-396M | $-482M | $-783M | $-441M | $-1.86B | · | $-598M | $-365M | |
| Amort. of Intangibles | · | · | · | $1.20B | $1.20B | $1.20B | · | $1.30B | $1.30B | $1.30B | · | · | · | · | |
| Restructuring | $419M | $49M | $308M | $237M | $-74M | $621M | $656M | $217M | $1.10B | $10M | $1.80B | $138M | $-44M | $514M | |
| Other Non-cash | · | $-3.68B | · | · | · | $-3.68B | · | · | · | $-6.88B | · | · | · | · | |
| Operating Cash Flow | $835M | $2.62B | $5.35B | $4.60B | $-582M | $2.33B | $6.72B | $6.71B | $-1.78B | $1.09B | $5.24B | · | $1.21B | $8.58B | |
| CapEx | $533M | $436M | $845M | $602M | $618M | $564M | $917M | $651M | $637M | $704M | $1.04B | · | $1.14B | $1.00B | |
| Investing Cash Flow | $2.11B | $785M | $-6.15B | $-2.43B | $3.95B | $3.27B | $-1.62B | $-2.06B | $4.60B | $1.73B | $-11.00B | · | $3.31B | $-4.41B | |
| Debt Issued | · | · | $5.99B | $0 | · | · | $0 | $0 | · | · | $0 | · | · | $0 | |
| Net Debt Issued | · | · | · | · | · | $0 | · | · | · | $-1.25B | · | · | $-269M | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Financing Cash Flow | $-3.66B | $-2.86B | $596M | $-2.48B | $-3.20B | $-5.23B | $-5.11B | $-4.64B | $-2.46B | $-4.93B | $5.44B | · | $-2.77B | $-5.01B | |
| Net Change in Cash | $-727M | $563M | $-196M | $-301M | $213M | $375M | $-45M | $29M | $343M | $-2.14B | $-316M | · | $1.75B | $-869M | |
| Taxes Paid | $3.47B | $72M | $1.02B | $178M | $3.34B | $152M | $433M | $486M | $2.50B | $184M | $240M | · | $329M | $2.95B | |
| Free Cash Flow | · | $2.18B | · | · | · | $1.77B | · | · | · | $386M | · | · | $73M | · | |
| Levered FCF | · | $1.61B | · | · | · | $1.07B | · | · | · | $-336M | · | · | $-209M | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | -1.7% | 18.6% | · | 21.3% | 19.9% | 21.6% | · | 25.2% | 0.31% | 20.9% | · | 18.3% | 30.3% | · | |
| Pretax Margin | -4.3% | 21.9% | · | 20.0% | 20.8% | 20.3% | · | 26.6% | -0.78% | 23.0% | · | 17.8% | 34.3% | · | |
| EBITDA Margin | 10.8% | 11.2% | · | 10.0% | 11.1% | 11.8% | · | · | · | 11.7% | · | · | · | · | |
| ROA | -0.12% | 1.3% | · | 1.7% | 1.4% | 1.4% | · | 2.1% | 0.02% | 1.5% | · | · | · | · | |
| ROE | -0.29% | 3.0% | · | 3.8% | 3.3% | 3.2% | · | 4.7% | 0.04% | 3.2% | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.2 | · | 1.3 | 1.2 | 1.3 | · | 1.0 | 0.9 | 1.0 | · | · | · | · | |
| Quick Ratio | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.3 | · | · | · | · | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.8 | 0.8 | · | · | · | · | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | · | · | · |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | |
| Inventory Turnover | 0.4 | 0.3 | · | 0.4 | 0.3 | 0.3 | · | 0.5 | 0.3 | 0.3 | · | · | · | · | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.4 | 1.2 | 1.3 | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $2.64 | $2.52 | · | $2.91 | $2.57 | $2.40 | · | $3.10 | $2.33 | $2.61 | · | $2.23 | $3.19 | · | |
| Cash Flow / Share | · | $0.46 | · | · | · | $0.41 | · | · | · | $0.19 | · | · | $0.21 | · | |
| Dividend / Share | $0.86 | $0.00 | $0.86 | $0.00 | $0.86 | $0.00 | $0.85 | $0.00 | $0.84 | $0.00 | $0.83 | $0.82 | $0.00 | $0.41 | |
| EPS (TTM) | $0.76 | $1.31 | · | $1.72 | $1.88 | $1.38 | · | $0.75 | $-0.45 | $-0.05 | · | $3.76 | $5.08 | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $63.70B | $63.31B | · | $62.78B | $63.83B | $62.46B | · | $60.43B | $56.22B | $55.95B | · | $79.27B | $94.00B | · | |
| Net Income TTM | $4.33B | $7.49B | · | $9.83B | $10.75B | $7.88B | · | $4.25B | $-2.60B | $-309M | · | $21.47B | $29.05B | · | |
| P/E | 32.0 | 20.6 | · | 13.8 | 12.9 | 18.3 | · | 38.8 | -62.2 | -555.0 | · | 9.8 | 8.0 | · | |
| Earnings Yield | 3.1% | 4.8% | · | 7.2% | 7.8% | 5.5% | · | 2.6% | -1.6% | -0.18% | · | 10.2% | 12.4% | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $62.58B | $63.63B | $59.55B | $101.17B | $81.29B |
| Net Gelir | $7.77B | $8.03B | $2.12B | $31.37B | $21.98B |
| Seyreltilmiş Hisse Başı Kâr | $1.36 | $1.41 | $0.37 | $5.47 | $3.85 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.7 | 0.7 | 0.8 | 0.4 | 0.5 |
| Cari Oran | 1.2 | 1.2 | 0.9 | 1.2 | 1.4 |
| Cari Oran | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $9.07B | $9.84B | $4.79B | $26.03B | $29.87B |
Kurumsal Sahipler (13F) 3.130 dosya · $107.9B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
3.130
Tutulan Değer
$107.9B
Yeni pozisyonlar
136
Çıkan pozisyonlar
218
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 136 (-170 önceki Ç'ye göre) | 218 (+51 önceki Ç'ye göre) | 1.185 (-142 önceki Ç'ye göre) | 1.245 (+127 önceki Ç'ye göre) | +44.6M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $13.479.519.929 | 541.346.182 | 12,49% | Hisse senetleri |
| BlackRock, Inc. | $12.754.464.030 | 529.670.433 | 11,82% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.961.368.437 | 372.149.852 | 8,31% | Hisse senetleri |
| STATE STREET CORP | $7.394.748.800 | 307.090.897 | 6,85% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $3.245.359.604 | 135.275.782 | 3,01% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.871.179.523 | 119.235.030 | 2,66% | Hisse senetleri |
| Fisher Asset Management, LLC | $2.626.340.379 | 109.067.291 | 2,43% | Hisse senetleri |
| MORGAN STANLEY | $2.319.998.579 | 96.345.452 | 2,15% | Hisse senetleri |
| NORGES BANK | $1.481.054.511 | 61.505.586 | 1,37% | Hisse senetleri |
| NORTHERN TRUST CORP | $1.422.756.518 | 59.084.573 | 1,32% | Hisse senetleri |
| Bank of New York Mellon Corp | $1.393.739.465 | 57.879.546 | 1,29% | Hisse senetleri |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $1.381.020.334 | 56.551.011 | 1,28% | Hisse senetleri |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $1.312.566.125 | 54.508.560 | 1,22% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $1.276.043.730 | 52.991.850 | 1,18% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.265.361.447 | 52.548.228 | 1,17% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $1.049.601.671 | 43.588.109 | 0,97% | Hisse senetleri |
| Legal & General Group Plc | $1.041.053.583 | 43.233.122 | 0,97% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $969.403.932 | 34.522.932 | 0,90% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $916.633.394 | 38.060.345 | 0,85% | Hisse senetleri |
| Amundi | $807.487.662 | 33.533.616 | 0,75% | Hisse senetleri |
| ROYAL BANK OF CANADA | $790.167.000 | 32.814.260 | 0,73% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $770.701.325 | 32.005.869 | 0,71% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $758.327.792 | 31.492.018 | 0,70% | Hisse senetleri |
| Invesco Ltd. | $705.717.588 | 29.307.209 | 0,65% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $670.051.958 | 27.826.078 | 0,62% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $582.923.824 | 24.207.800 | 0,54% | Alım opsiyonu |
| JPMORGAN CHASE & CO | $560.759.659 | 23.010.244 | 0,52% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $557.517.016 | 23.152.700 | 0,52% | Satım opsiyonu |
| Capital World Investors | $535.014.038 | 22.218.190 | 0,50% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $525.396.686 | 21.818.803 | 0,49% | Hisse senetleri |
| FEDERATED HERMES, INC. | $501.486.337 | 20.825.845 | 0,46% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $486.263.674 | 20.193.675 | 0,45% | Hisse senetleri |
| PeakShares LLC | $470.788.000 | 19.551 | 0,44% | Hisse senetleri |
| CITIGROUP INC | $463.013.015 | 19.228.115 | 0,43% | Hisse senetleri |
| CITADEL ADVISORS LLC | $459.511.416 | 19.082.700 | 0,43% | Satım opsiyonu |
| AQR CAPITAL MANAGEMENT LLC | $445.018.217 | 18.557.891 | 0,41% | Hisse senetleri |
| UBS Group AG | $437.007.632 | 18.148.158 | 0,41% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $428.614.224 | 17.799.594 | 0,40% | Hisse senetleri |
| California Public Employees Retirement System | $415.668.791 | 17.261.993 | 0,39% | Hisse senetleri |
| BARCLAYS PLC | $403.262.967 | 16.746.801 | 0,37% | Hisse senetleri |
| HSBC HOLDINGS PLC | $402.358.982 | 16.704.156 | 0,37% | Hisse senetleri |
| VAN ECK ASSOCIATES CORP | $399.361.911 | 16.584.797 | 0,37% | Hisse senetleri |
| Swiss National Bank | $386.334.993 | 16.043.812 | 0,36% | Hisse senetleri |
| FMR LLC | $370.766.866 | 15.397.294 | 0,34% | Hisse senetleri |
| Unisphere Establishment | $352.772.000 | 14.650.000 | 0,33% | Hisse senetleri |
| National Pension Service | $349.892.971 | 14.530.439 | 0,32% | Hisse senetleri |
| Nuveen, LLC | $347.854.529 | 14.445.787 | 0,32% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $345.898.478 | 14.364.565 | 0,32% | Hisse senetleri |
| Mitsubishi UFJ Asset Management Co., Ltd. | $338.582.667 | 14.060.742 | 0,31% | Hisse senetleri |
| LPL Financial LLC | $335.189.276 | 13.919.821 | 0,31% | Hisse senetleri |
Aktivistler ve %5+ sahipler 15 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Pfizer Inc. (“Pfizer”) ×9 başvurular | 05 Ağustos 2024 | · | İlk başvuru | · | SEC |
| Pfizer Inc. (“ Pfizer ”) | 06 Kasım 2020 | · | İlk başvuru | Pasif yatırım | SEC |
| Pfizer Inc. IRS Identification Nos. of above persons (entities only), Pfizer Holdings Europe IRS Identification Nos. of above persons (entities only) ×2 başvurular | 17 Mart 2016 | · | İlk başvuru | · | SEC |
| IRS Identification Nos. of above persons (entities only) Pfizer Inc., IRS Identification Nos. of above persons (entities only) Pfizer Holdings Europe | 01 Mayıs 2015 | · | İlk başvuru | Pasif yatırım | SEC |
| Pfizer Inc., Eclipse Acquisition Corp. ×11 başvurular | 03 Kasım 2011 | · | İlk başvuru | M&A / satış | SEC |
| Açıklanmayan raporlama kişisi | 11 Nisan 2008 | · | İlk başvuru | M&A / satış | SEC |
| G. D. Searle LLC, IRS Identification Nos. of above persons (entities only) Pfizer Inc. | 11 Eylül 2007 | · | İlk başvuru | · | SEC |
| Pfizer Inc.;, Pfizer Holdings Europe (no IRS Identification No.) ×3 başvurular | 14 Şubat 2006 | · | İlk başvuru | · | SEC |
| Pfizer Overseas Pharmaceuticals, Pfizer, Inc. ; ×5 başvurular | 14 Şubat 2006 | · | İlk başvuru | · | SEC |
| Pfizer Overseas Pharmaceuticals (formerly named Pfizer Ireland Pharmaceuticals), Pfizer, Inc. ; ×2 başvurular | 14 Şubat 2006 | · | İlk başvuru | · | SEC |
| G.D. Searle LLC;, Pfizer, Inc. ; | 02 Şubat 2005 | · | İlk başvuru | · | SEC |
| Pfizer Ireland Pharmaceuticals, Pfizer Inc.; | 13 Şubat 2004 | · | İlk başvuru | · | SEC |
| Warner-Lambert Company LLC;, Pfizer Inc. | 17 Eylül 2003 | · | İlk başvuru | · | SEC |
| Pfizer Holdings Europe, Pfizer Inc. | 24 Mart 2003 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 16 Mart 2001 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 89 içeriden öğrenenler · 26 yöneticiler · 24 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Albert Bourla | Chairman & CEO | 30 Eylül 2026 A | 429.173 | 1 | 0 | $1.000.920 |
| Jeffrey B Kindler | Former Chairman & CEO | 15 Aralık 2010 A | 826.631 | 0 | 0 | $0 |
| Geno J Germano | Group President | 26 Şubat 2015 A | 308.254 | 0 | 0 | $0 |
| Olivier Brandicourt | Business Unit President | 31 Ekim 2013 A | 191.076 | 0 | 0 | $0 |
| David S Simmons | Business Unit President | 31 Mayıs 2012 A | 179.880 | 0 | 0 | $0 |
| Cavan M. Redmond | Group President | 31 Mayıs 2012 A | 151.138 | 0 | 0 | $0 |
| Anthony J Maddaluna | Executive Vice President | 30 Aralık 2016 A | 112.087 | 0 | 0 | $0 |
| Amy Schulman | Former Exec. Vice President | 31 Aralık 2013 A | 223.497 | 0 | 0 | $0 |
| Kristin C Peck | Executive Vice President | 31 Ekim 2012 A | 43.400 | 0 | 0 | $0 |
| Natale S Ricciardi | Senior Vice President | 31 Mart 2011 A | 394.778 | 0 | 0 | $0 |
| Mary S Mcleod | Former Sr. Vice President | 15 Aralık 2010 A | 120.833 | 0 | 0 | $0 |
| Martin Mackay | Senior Vice President | 14 Mayıs 2010 A | 375.044 | 0 | 0 | $0 |
| William R Ringo | Senior Vice President | 31 Mart 2010 A | 252.798 | 0 | 0 | $0 |
| Corey S Goodman | Senior Vice President | 30 Nisan 2009 A | 82.232 | 0 | 0 | $0 |
| Joseph M Feczko | Senior Vice President | 13 Mart 2009 A | 428.855 | 0 | 0 | $0 |
| Richard H Bagger | Senior Vice President | 31 Aralık 2008 A | 54.877 | 0 | 0 | $0 |
| Allen P Waxman | Senior Vice President | 28 Şubat 2008 F | 62.341 | 0 | 0 | $0 |
| David L Shedlarz | Vice Chairman | 31 Aralık 2007 A | 609.310 | 0 | 0 | $0 |
| John L Lamattina | Senior Vice President | 15 Ekim 2007 A | 383.190 | 0 | 0 | $0 |
| Alan G Levin | Senior Vice President | 14 Eylül 2007 A | 340.061 | 0 | 0 | $0 |
| Sylvia M Montero | Senior Vice President | 29 Aralık 2006 A | · | 0 | 0 | $0 |
| Karen L Katen | Vice Chairman | 15 Ağustos 2006 A | 941.284 | 0 | 0 | $0 |
| Peter B Corr | Senior Vice President | 24 Şubat 2005 A | 148.866 | 0 | 0 | $0 |
| Charles L Hardwick | Senior Vice President | 24 Şubat 2005 A | 70.094 | 0 | 0 | $0 |
| Yvonne R Jackson | Senior VP - Human Resources | 24 Şubat 2005 F | 13.507 | 0 | 0 | $0 |
| John W Mitchell | Senior Vice President | 31 Aralık 2004 I | 746.148 | 0 | 0 | $0 |
| Mortimer J Buckley | Yönetim kurulu üyesi | 25 Eylül 2026 A | 37.632 | 1 | 0 | $960.369 |
| Joseph Echevarria | Yönetim kurulu üyesi | 25 Eylül 2026 A | · | 0 | 0 | $0 |
| James C Smith | Yönetim kurulu üyesi | 25 Eylül 2026 A | 1.542 | 0 | 0 | $0 |
| James Quincey | Yönetim kurulu üyesi | 25 Eylül 2026 A | · | 0 | 0 | $0 |
| Cyrus Taraporevala | Yönetim kurulu üyesi | 25 Eylül 2026 A | · | 0 | 0 | $0 |
| Shantanu Narayen | Yönetim kurulu üyesi | 25 Eylül 2026 A | · | 0 | 0 | $0 |
| Marc Tessier-Lavigne | Yönetim kurulu üyesi | 23 Nisan 2015 A | · | 0 | 0 | $0 |
| George A Lorch | Yönetim kurulu üyesi | 24 Nisan 2014 A | 24.126 | 0 | 0 | $0 |
| Constance J Horner | Yönetim kurulu üyesi | 24 Nisan 2014 A | · | 0 | 0 | $0 |
| Anthony M Burns | Yönetim kurulu üyesi | 25 Nisan 2013 A | 23.989 | 0 | 0 | $0 |
| Iii William H Gray | Yönetim kurulu üyesi | 25 Nisan 2013 A | 26 | 0 | 0 | $0 |
| John P Mascotte | Yönetim kurulu üyesi | 26 Nisan 2012 A | 3.940 | 0 | 0 | $0 |
| Michael S Brown | Yönetim kurulu üyesi | 28 Nisan 2011 A | · | 0 | 0 | $0 |
| William C Steere JR | Yönetim kurulu üyesi | 01 Nisan 2011 A | 1.265.131 | 0 | 0 | $0 |
| BURT ROBERT N | Yönetim kurulu üyesi | 22 Nisan 2010 A | 12.200 | 0 | 0 | $0 |
| Dana G Mead | Yönetim kurulu üyesi | 01 Nisan 2010 A | 9.350 | 0 | 0 | $0 |
| William R Howell | Yönetim kurulu üyesi | 24 Nisan 2008 A | · | 0 | 0 | $0 |
| Henry A Mckinnell | Yönetim kurulu üyesi | 28 Şubat 2007 A | 2.134.851 | 0 | 0 | $0 |
| Ruth J Simmons | Yönetim kurulu üyesi | 27 Nisan 2006 A | 1.200 | 0 | 0 | $0 |
| Stanley Ikenberry | Yönetim kurulu üyesi | 27 Nisan 2006 A | · | 0 | 0 | $0 |
| Jean Paul Valles | Yönetim kurulu üyesi | 28 Nisan 2005 A | 641.854 | 0 | 0 | $0 |
| Franklin D Raines | Yönetim kurulu üyesi | 01 Nisan 2005 A | · | 0 | 0 | $0 |
| Pfizer Inc. | 10% sahip | 17 Aralık 2003 J | 3.273.679 | 0 | 0 | $0 |
| Jennifer B. Damico | · | 05 Ağustos 2026 S | 28.611 | 0 | 2 | $-134.661 |
| Ronald E Blaylock | · | 05 Ağustos 2026 P | 66.938 | 1 | 0 | $998.821 |
| Dan R. Littman | · | 23 Nisan 2026 A | · | 0 | 0 | $0 |
| Susan Desmond-Hellmann | · | 23 Nisan 2026 A | · | 0 | 0 | $0 |
| Scott Gottlieb | · | 23 Nisan 2026 A | 10.000 | 0 | 0 | $0 |
| Johnson Suzanne M Nora | · | 23 Nisan 2026 A | 10.000 | 0 | 0 | $0 |
| Andrew Baum | · | 03 Mart 2026 A | · | 0 | 0 | $0 |
| Alexandre De Germay | · | 03 Mart 2026 A | 74.377 | 0 | 0 | $0 |
| Christoffel Boshoff | · | 03 Mart 2026 A | 161.379 | 0 | 0 | $0 |
| Michael Mcdermott | · | 03 Mart 2026 A | 74.308 | 0 | 0 | $0 |
| Aamir Malik | · | 03 Mart 2026 A | 29.548 | 0 | 0 | $0 |
| Payal Sahni | · | 03 Mart 2026 A | 27.667 | 0 | 0 | $0 |
| Douglas M Lankler | · | 03 Mart 2026 A | 163.177 | 0 | 0 | $0 |
| Lidia Fonseca | · | 03 Mart 2026 A | 46.455 | 0 | 0 | $0 |
| David M Denton | · | 03 Mart 2026 A | 37.919 | 0 | 0 | $0 |
| Susan Hockfield | · | 24 Nisan 2025 A | · | 0 | 0 | $0 |
| Sally Susman | · | 04 Mart 2025 A | 168.909 | 0 | 0 | $0 |
| Rady A Johnson | · | 31 Aralık 2024 A | 97.153 | 0 | 0 | $0 |
| Mikael Dolsten | · | 12 Eylül 2024 A | 321.729 | 0 | 0 | $0 |
| Helen Hobbs | · | 25 Nisan 2024 A | · | 0 | 0 | $0 |
| Angela Hwang | · | 10 Mayıs 2023 I | 29.778 | 0 | 0 | $0 |
| William Pao | · | 31 Mart 2023 F | 97.765 | 0 | 0 | $0 |
| William R Carapezzi JR | · | 12 Mayıs 2022 S | 38.146 | 0 | 0 | $0 |
| Frank A Damelio | · | 26 Şubat 2022 M | 555.941 | 0 | 0 | $0 |
| John D Young | · | 15 Aralık 2021 A | 312.704 | 0 | 0 | $0 |
| Alexander R Mackenzie | · | 02 Aralık 2021 S | 87.280 | 0 | 0 | $0 |
| James M Kilts | · | 25 Eylül 2020 A | 0 | 0 | 0 | $0 |
| Dawn Rogers | · | 15 Haziran 2020 A | 4.823 | 0 | 0 | $0 |
| Don W Cornwell | · | 23 Nisan 2020 A | 0 | 0 | 0 | $0 |
| Michael Goettler | · | 28 Şubat 2020 M | 36.812 | 0 | 0 | $0 |
| Loretta V Cangialosi | · | 28 Şubat 2020 M | 122.075 | 0 | 0 | $0 |
| Ian C Read | · | 04 Mart 2019 S | 1.109.202 | 0 | 0 | $0 |
| Freda C Lewis-Hall | · | 28 Şubat 2019 A | 375.244 | 0 | 0 | $0 |
| Laurie J Olson | · | 13 Ağustos 2018 S | 72.672 | 0 | 0 | $0 |
| Kirsten Lund-Jurgensen | · | 01 Ağustos 2018 S | 4.643 | 0 | 0 | $0 |
| Dennis A Ausiello | · | 26 Nisan 2018 A | 887 | 0 | 0 | $0 |
| Stephen W Sanger | · | 29 Mart 2018 A | 85 | 0 | 0 | $0 |
| Charles H Hill | · | 06 Mart 2018 S | 57.328 | 0 | 0 | $0 |
| Frances D Fergusson | · | 27 Nisan 2017 A | · | 0 | 0 | $0 |
| Robert W Norton | · | 31 Aralık 2003 A | 248.900 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 165 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 5,61% | 1.097.883 SH | 01 Ekim 2026 | Günlük |
| HDV · iShares Trust | 4,66% | 25.857.763 SH | 11 Eylül 2026 | Günlük |
| IHE · iShares Trust | 4,56% | 2.670.093 SH | 11 Eylül 2026 | Günlük |
| SPHD · Invesco Exchange-Traded Fund Trust … | 3,80% | 4.218.647 SH | 01 Ekim 2026 | Günlük |
| PEY · Invesco Exchange-Traded Fund Trust | 2,90% | 1.091.124 SH | 01 Ekim 2026 | Günlük |
| IYH · iShares Trust | 2,54% | 3.333.009 SH | 11 Eylül 2026 | Günlük |
| PAYR · Federated Hermes ETF Trust | 2,51% | 57.250 NS | 31 Temmuz 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,35% | 985.502 NS | 31 Temmuz 2026 | N-PORT |
| DVY · iShares Trust | 2,24% | 19.063.533 SH | 11 Eylül 2026 | Günlük |
| FDV · Federated Hermes ETF Trust | 2,24% | 787.273 NS | 31 Temmuz 2026 | N-PORT |
| BMVP · Invesco Exchange-Traded Fund Trust | 2,11% | 73.565 SH | 01 Ekim 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 2,06% | 2.705.939 NS | 31 Temmuz 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 2,02% | 17.099.868 SH | 19 Ağustos 2026 | Günlük |
| IXJ · iShares Trust | 2,00% | 2.998.095 SH | 11 Eylül 2026 | Günlük |
| LYLD · Cambria ETF Trust | 1,95% | 5.645 NS | 31 Temmuz 2026 | N-PORT |
| GCOW · Pacer Funds Trust | 1,85% | 2.539.373 NS | 31 Temmuz 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 1,84% | 13.728.675 NS | 31 Temmuz 2026 | N-PORT |
| DIV · Global X Funds | 1,80% | 565.544 NS | 31 Temmuz 2026 | N-PORT |
| SPDV · ETF Series Solutions | 1,73% | 90.905 NS | 31 Temmuz 2026 | N-PORT |
| VLUE · iShares Trust | 1,70% | 5.895.715 SH | 11 Eylül 2026 | Günlük |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,68% | 513.428 SH | 01 Ekim 2026 | Günlük |
| LQAI · Exchange Listed Funds Trust | 1,64% | 1.459 NS | 31 Temmuz 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1,63% | 112.150 NS | 31 Temmuz 2026 | N-PORT |
| NULV · Nushares ETF Trust | 1,49% | 1.308.622 NS | 31 Temmuz 2026 | N-PORT |
| DIVB · iShares Trust | 1,30% | 958.549 SH | 11 Eylül 2026 | Günlük |
| GDIV · Harbor ETF Trust | 1,30% | 122.064 NS | 31 Temmuz 2026 | N-PORT |
| DIVD · EA Series Trust | 1,17% | 10.041 NS | 31 Temmuz 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,11% | 9.176 NS | 31 Temmuz 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 1,05% | 1.050.211 NS | 31 Temmuz 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1,05% | 1.013.851 SH | 01 Ekim 2026 | Günlük |
| SYLD · Cambria ETF Trust | 0,96% | 382.605 NS | 31 Temmuz 2026 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,94% | 242.900 NS | 31 Temmuz 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0,91% | 33.339 NS | 31 Temmuz 2026 | N-PORT |
| XT · iShares Trust | 0,90% | 1.255.272 SH | 11 Eylül 2026 | Günlük |
| BSCQ · Invesco Exchange-Traded Self-Indexe… | 0,89% | 28.655.000 | 01 Ekim 2026 | Günlük |
| NUDV · Nushares ETF Trust | 0,89% | 17.826 NS | 31 Temmuz 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,83% | 2.847.711 SH | 01 Ekim 2026 | Günlük |
| FDRR · FIDELITY COVINGTON TRUST | 0,81% | 238.562 NS | 31 Temmuz 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,76% | 2.051.163 NS | 31 Temmuz 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,75% | 4.643.669 NS | 31 Temmuz 2026 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,71% | 399.397 NS | 31 Temmuz 2026 | N-PORT |
| IIGD · Invesco Exchange-Traded Self-Indexe… | 0,70% | 190.000 | 01 Ekim 2026 | Günlük |
| CVAR · ETF Opportunities Trust | 0,68% | 11.625 NS | 31 Temmuz 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,68% | 227.294 SH | 01 Ekim 2026 | Günlük |
| NULC · Nushares ETF Trust | 0,65% | 18.363 NS | 31 Temmuz 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0,65% | 3.582.302 SH | 19 Ağustos 2026 | Günlük |
| FHEQ · Fidelity Greenwood Street Trust | 0,65% | 240.601 NS | 31 Temmuz 2026 | N-PORT |
| VMAX · Lattice Strategies Trust | 0,64% | 12.610 NS | 31 Temmuz 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,61% | 215.331 SH | 19 Ağustos 2026 | Günlük |
| FVAL · FIDELITY COVINGTON TRUST | 0,61% | 323.509 NS | 31 Temmuz 2026 | N-PORT |
| PFM · Invesco Exchange-Traded Fund Trust | 0,60% | 162.902 SH | 01 Ekim 2026 | Günlük |
| FEUS · FlexShares Trust | 0,60% | 26.840 NS | 31 Temmuz 2026 | N-PORT |
| IWX · iShares Trust | 0,58% | 822.366 SH | 11 Eylül 2026 | Günlük |
| VYM · VANGUARD WHITEHALL FUNDS | 0,57% | 22.722.554 SH | 19 Ağustos 2026 | Günlük |
| BKDV · BNY Mellon ETF Trust II | 0,53% | 390.108 NS | 31 Temmuz 2026 | N-PORT |
| IVE · iShares Trust | 0,53% | 9.466.799 SH | 11 Eylül 2026 | Günlük |
| VTV · VANGUARD INDEX FUNDS | 0,51% | 54.192.320 SH | 19 Ağustos 2026 | Günlük |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,50% | 14.919.000 | 01 Ekim 2026 | Günlük |
| IUSV · iShares Trust | 0,50% | 4.987.037 SH | 11 Eylül 2026 | Günlük |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,50% | 643.000 | 01 Ekim 2026 | Günlük |
| OEI · Listed Funds Trust | 0,48% | 8.950 NS | 31 Temmuz 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,47% | 1.312.357 SH | 19 Ağustos 2026 | Günlük |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,47% | 156.260 NS | 31 Temmuz 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,47% | 292.581 NS | 31 Temmuz 2026 | N-PORT |
| ILCV · iShares Trust | 0,46% | 220.546 SH | 11 Eylül 2026 | Günlük |
| FBUF · Fidelity Greenwood Street Trust | 0,45% | 4.314 NS | 31 Temmuz 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,44% | 127.850 SH | 19 Ağustos 2026 | Günlük |
| IWD · iShares Trust | 0,42% | 12.653.051 SH | 11 Eylül 2026 | Günlük |
| RPV · Invesco Exchange-Traded Fund Trust | 0,42% | 239.793 SH | 01 Ekim 2026 | Günlük |
| LRGF · iShares Trust | 0,41% | 545.518 SH | 11 Eylül 2026 | Günlük |
| DFVX · Dimensional ETF Trust | 0,39% | 82.954 NS | 31 Temmuz 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,38% | 11.789.000 | 01 Ekim 2026 | Günlük |
| IOO · iShares Trust | 0,38% | 1.247.283 SH | 11 Eylül 2026 | Günlük |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,38% | 3.436.316 SH | 19 Ağustos 2026 | Günlük |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,36% | 24.124 NS | 31 Temmuz 2026 | N-PORT |
| EVUS · iShares Trust | 0,36% | 49.268 SH | 11 Eylül 2026 | Günlük |
| HAPI · Harbor ETF Trust | 0,34% | 66.415 NS | 31 Temmuz 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,34% | 1.143.095 SH | 01 Ekim 2026 | Günlük |
| EGLE · Global X Funds | 0,33% | 290 NS | 31 Temmuz 2026 | N-PORT |
| OEF · iShares Trust | 0,33% | 2.412.320 SH | 11 Eylül 2026 | Günlük |
| FYEE · Fidelity Greenwood Street Trust | 0,33% | 28.563 NS | 31 Temmuz 2026 | N-PORT |
| HUSV · First Trust Exchange-Traded Fund III | 0,33% | 9.631 NS | 31 Temmuz 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,31% | 87.648 NS | 31 Temmuz 2026 | N-PORT |
| USCL · iShares Trust | 0,30% | 301.659 SH | 10 Eylül 2026 | Günlük |
| TOPC · iShares Trust | 0,29% | 3.453 SH | 11 Eylül 2026 | Günlük |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,29% | 168.415 SH | 01 Ekim 2026 | Günlük |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,28% | 51.648 NS | 31 Temmuz 2026 | N-PORT |
| IWL · iShares Trust | 0,28% | 221.494 SH | 11 Eylül 2026 | Günlük |
| XVV · iShares Trust | 0,27% | 65.658 SH | 11 Eylül 2026 | Günlük |
| DYNF · BlackRock ETF Trust | 0,27% | 4.037.182 SH | 11 Eylül 2026 | Günlük |
| FDVV · FIDELITY COVINGTON TRUST | 0,27% | 1.077.066 NS | 31 Temmuz 2026 | N-PORT |
| MGC · VANGUARD WORLD FUND | 0,26% | 1.139.734 SH | 19 Ağustos 2026 | Günlük |
| PBP · Invesco Exchange-Traded Fund Trust | 0,25% | 33.905 SH | 01 Ekim 2026 | Günlük |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,25% | 983.533 SH | 01 Ekim 2026 | Günlük |
| IVV · iShares Trust | 0,24% | 71.807.189 SH | 11 Eylül 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,24% | 1.287.392 SH | 19 Ağustos 2026 | Günlük |
| ILCB · iShares Trust | 0,24% | 110.304 SH | 11 Eylül 2026 | Günlük |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,23% | 10.423.000 | 01 Ekim 2026 | Günlük |
| ESGU · iShares Trust | 0,23% | 1.466.183 SH | 11 Eylül 2026 | Günlük |
| ADME · ETF Series Solutions | 0,23% | 26.445 NS | 31 Temmuz 2026 | N-PORT |
| IYY · iShares Trust | 0,22% | 244.557 SH | 11 Eylül 2026 | Günlük |
| CRBN · iShares Trust | 0,22% | 94.860 SH | 11 Eylül 2026 | Günlük |
| IWB · iShares Trust | 0,22% | 3.940.324 SH | 11 Eylül 2026 | Günlük |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,22% | 8.098.441 | 01 Ekim 2026 | Günlük |
| XYLD · Global X Funds | 0,22% | 289.830 NS | 31 Temmuz 2026 | N-PORT |
| XRMI · Global X Funds | 0,22% | 4.435 NS | 31 Temmuz 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,22% | 288.629 NS | 31 Temmuz 2026 | N-PORT |
| ACIO · ETF Series Solutions | 0,22% | 208.133 NS | 31 Temmuz 2026 | N-PORT |
| VV · VANGUARD INDEX FUNDS | 0,22% | 6.656.238 SH | 19 Ağustos 2026 | Günlük |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 781.780 NS | 31 Temmuz 2026 | N-PORT |
| TOV · EA Series Trust | 0,22% | 23.725 NS | 31 Temmuz 2026 | N-PORT |
| XYLG · Global X Funds | 0,22% | 5.634 NS | 31 Temmuz 2026 | N-PORT |
| GLOF · iShares Trust | 0,22% | 15.931 SH | 11 Eylül 2026 | Günlük |
| XTR · Global X Funds | 0,22% | 421 NS | 31 Temmuz 2026 | N-PORT |
| XCLR · Global X Funds | 0,22% | 312 NS | 31 Temmuz 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,22% | 95.884 NS | 31 Temmuz 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,22% | 476.345 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,22% | 1.569.616 SH | 11 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,22% | 7.433.657 SH | 11 Eylül 2026 | Günlük |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 7.041.435 SH | 01 Ekim 2026 | Günlük |
| VOO · VANGUARD INDEX FUNDS | 0,21% | 148.055.512 SH | 19 Ağustos 2026 | Günlük |
| PHDG · Invesco Actively Managed Exchange-T… | 0,21% | 4.490 SH | 01 Ekim 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,21% | 1.719.178 NS | 31 Temmuz 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,20% | 21.504 NS | 31 Temmuz 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,20% | 137.341 NS | 31 Temmuz 2026 | N-PORT |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,20% | 938.753 SH | 19 Ağustos 2026 | Günlük |
| EUSA · iShares, Inc. | 0,20% | 138.171 SH | 11 Eylül 2026 | Günlük |
| DCOR · Dimensional ETF Trust | 0,20% | 265.049 NS | 31 Temmuz 2026 | N-PORT |
| SIZE · iShares Trust | 0,19% | 29.780 SH | 11 Eylül 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,19% | 180.976.007 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,19% | 479.516 SH | 19 Ağustos 2026 | Günlük |
| DFAU · Dimensional ETF Trust | 0,19% | 932.512 NS | 31 Temmuz 2026 | N-PORT |
| TOK · iShares Trust | 0,18% | 15.688 SH | 11 Eylül 2026 | Günlük |
| TILT · FlexShares Trust | 0,18% | 154.208 NS | 31 Temmuz 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,18% | 39.662 NS | 31 Temmuz 2026 | N-PORT |
| URTH · iShares, Inc. | 0,17% | 511.839 SH | 11 Eylül 2026 | Günlük |
| DFSU · Dimensional ETF Trust | 0,17% | 153.594 NS | 31 Temmuz 2026 | N-PORT |
| PEVC · Pacer Funds Trust | 0,17% | 161 NS | 31 Temmuz 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,17% | 445.582 NS | 31 Temmuz 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,16% | 12.827 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,15% | 2.930.879 NS | 31 Temmuz 2026 | N-PORT |
| ACWI · iShares Trust | 0,15% | 1.803.698 SH | 11 Eylül 2026 | Günlük |
| LGDX · Tidal Trust III | 0,15% | 8.315 NS | 31 Temmuz 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0,13% | 303 NS | 31 Temmuz 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,12% | 4.732.591 SH | 19 Ağustos 2026 | Günlük |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,11% | 178.322 SH | 01 Ekim 2026 | Günlük |
| GSY · Invesco Actively Managed Exchange-T… | 0,11% | 4.039.000 | 01 Ekim 2026 | Günlük |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 27.290 SH | 01 Ekim 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,09% | 20.575 NS | 31 Temmuz 2026 | N-PORT |
| JFLI · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 1.786 NS | 31 Temmuz 2026 | N-PORT |
| QLC · FlexShares Trust | 0,08% | 32.704 NS | 31 Temmuz 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0,01% | 359.000 | 01 Ekim 2026 | Günlük |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Temmuz 2026 | Günlük |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Temmuz 2026 | Günlük |
| BNDX · VANGUARD CHARLOTTE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCEB · VANGUARD WORLD FUND | · | · | 30 Temmuz 2026 | Günlük |
PFE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 36 analist
TUT
Medyan hedef
$28.00
+0,7%
6 16,7%
Güçlü Al
8 22,2%
Al
20 55,6%
Tut
1 2,8%
Sat
1 2,8%
Güçlü Sat
12 Aylık Fiyat Hedefi
26 analist · 2026-09-29Ortalama hedef $28.88 +3,9%
Şimdi
Mevcut fiyat $27.80
Düşük$25.00
Ortalama$28.88
Yüksek$35.75
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| PFE | · | 18.3 | -1.7% | 12.4% | 8.9% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
| JNJ | · | 18.8 | 6.0% | 28.5% | 35.0% | 67.9% |
| MRK | · | 14.5 | 1.3% | 28.1% | 36.9% | · |
| BMY | · | 15.6 | -0.22% | 14.6% | 40.5% | · |
| RPRX | · | 21.7 | 5.1% | 32.4% | 8.0% | · |
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | · |
| VTRS | · | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | · |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
Son Haberler Bu şirketten bahseden son manşetler
Here Are My Top 2 High-Yield Healthcare Stocks to Buy Now
Nasdaq · 3 gün, 22 saat önce
Kevin Warsh Just Signaled Higher-for-Longer Rates. Here's What That Means for Big Pharma Dividend Stocks.
Nasdaq · 6 gün, 6 saat önce
AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September?
Nasdaq · 1 hafta, 4 gün önce
Cybersecurity Stocks Extend Gains on AI Safety Warnings: CrowdStrike and Okta Rise 4%, Palo Alto Ticks Up
Yahoo Finance · 1 hafta, 4 gün önce
4 Stocks Whup The S&P 500 — And Yield More Than 30-Year Treasurys
Yahoo Finance · 3 hafta, 4 gün önce
Pfizer's Stock Has Been a Dud Over the Past 5 Years, but Is It Still Worth Buying for Its 6.9% Yield?
Nasdaq · 2 ay önce
Pfizer Paid Out $14.6 Billion in Dividends Over the Last 18 Months. Can It Keep This Up Through the Patent Cliff?
Nasdaq · 2 ay, 2 hafta önce
Pfizer Vs. Amgen: Bet That Pfizer’s Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen
Yahoo Finance · 2 ay, 2 hafta önce
Pfizer vs Verizon Communications: Which High-Yielding Dividend Stock Is the Better Buy?
Nasdaq · 3 ay önce
This 7% Yielding Healthcare Powerhouse Belongs in Retirees’ Portfolios
Yahoo Finance · 3 ay önce
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 4, 2026